The Call for Opposition: Challenging the P2P and IOM Processes
In our second article on how to react to the publication of the draft P2P report, Gabby Klein provides her view of why she and a large group of advocates and patients are continuing their protest of the government’s ongoing control and manipulation of our disease via their processes...
Discuss the article on the Forums.

Gilenya approved for MS

Discussion in 'General Treatment' started by zoe.a.m., Sep 23, 2010.

  1. zoe.a.m.

    zoe.a.m. Senior Member

    Messages:
    361
    Likes:
    17
    Olympic Peninsula, Washington
    I just got news of this today and wonder if it might be helpful knowledge for someone! It appears to keep lymphocytes in the lymph nodes and keeps them from attacking the CNS. Sounds like a rough trade off in many ways and probably not a good choice for ME/CFS, but good to see a European drug company taking a stab at new treatments for chronic illnesses.

    http://www.nytimes.com/2010/09/23/business/23novartis.html?partner=rss&emc=rss
     

See more popular forum discussions.

Share This Page